Phase 2 Clinical Study in Psoriasis With Oral Investigational Drug VX-765
Clinical trial NCT00205465 · COMPLETED
Trial details
- NCT number
- NCT00205465
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-12-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.